EKF Diagnostics Holdings plc

EKF Diagnostics Holdings plc is a publicly listed healthcare company specializing in the development, manufacture, and distribution of point-of-care diagnostic devices and biotechnology solutions. Founded in 1990 in Germany and now headquartered in Penarth near Cardiff, UK, it focuses on innovative in-vitro diagnostics for hemoglobin, HbA1c, glucose, lactate, and clinical chemistry tests, alongside reagents, enzymes, and biomarker-based ELISA and rapid tests. The company operates manufacturing sites in the US and Germany, with subsidiaries including Stanbio Laboratory in Texas for clinical chemistry and enzyme production, and former entities like Argutus Medical and Quotient Diagnostics enhancing its diabetes management and biomarker portfolios. EKF Diagnostics Holdings plc serves healthcare professionals, laboratories, biotechnology, pharmaceutical, and life sciences sectors by enabling rapid, accurate testing at the point of care or in central labs. With products distributed to over 120 countries through a global network, it supports early detection, precise diagnosis, and therapeutic monitoring, playing a key role in advancing patient-centric healthcare and research applications worldwide.